Patients with hypersensitivity to any of the components of Belafcap.
Large doses (>1 g daily) of vitamin C in patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency. History of renal calculi, hyperoxaluria, oxalate dysbolism and thalassemia. Patients with vitamin A redundancy.